Skip to main content

Table 1 Patient summary

From: Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8

CLINICAL CHARACTERISTICS 71 tumors analyzed by CGH 27 tumors analyzed by both CGH and microarray 64 tumors analyzed by microarray
Median Age in months (mean; range) 80 (89.4; 7–458) 73 (93.6; 7–458) 74 (99.9; 7–458)
Median Follow-up in months (mean; range) 36 (39; 4–109) 39 (40.2; 7–80) 39 (46; 5–130)
Number of patients < 3 yr old [p value- OS:PFS] 14 [0.139:0.187] 7 [0.542:0.421] 11 [0.406:0.0005]*
STAGE (Chang) – M0: M+ [p value- OS:PFS] 54 : 17 [0.027*:0.111] 20 : 7 [0.058:0.222] 43 : 21 [0.047*:0.012*]
SEX- male: female [p value- OS:PFS] 51 : 20 [0.875:0.532] 18 : 9 [0.729:0.839] 42 : 22 [0.827:0.957]
SURGERY- Gross Total Resection: Subtotal Resection [p value- OS:PFS] 60 : 11 [0.0701:0.386] 18 : 9 [0.028*:0.427] 40 : 24 [0.0502:0.926]
CHEMOTHERAPY- Standard : PBSCT [p value- OS:PFS] 50:21 [0.825:0.972] 27:0 [NA] 64:0 [NA]
HISTOLOGY    
Classic[p value- OS:PFS] 30 [0.714:0.619] 16 [0.461:0.996] 44 [0.384:0.377]
Nodular or Desmoplastic[p value- OS:PFS] 21 [0.558:0.731] 8 [0.327:0.987] 15 [0.46:0.564]
Large cell or Anaplastic[p value- OS:PFS] 17 [0.844:0.830] NA NA
Intermediate or Other[p value- OS:PFS] 3 [0.935:0.995] 3 [0.769:0.985] 5 [0.736:0.532]
  1. Abbreviations: CGH, comparative genomic hybridization; OS, overall survival; PFS, progression-free survival; PBSCT, peripheral blood stem cell transplant; NA, not applicable.
  2. Log-rank p values were calculated for OS and PFS.
  3. *Statistically significant p values.